Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics...
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
Expands and further diversifies Emergent’s medical countermeasures portfolio with the addition of a small molecule therapeutic addressing a high priority public health threat Transaction to be...
Statement by Emergent BioSolutions’ Board of Directors
Gaithersburg, Md.– We mourn the loss of our founder and former CEO and executive chairman, Fuad El-Hibri, who died peacefully at home early Saturday surrounded by family and loved ones. Our hearts...
The Balancing Act Airing on Lifetime TV Features a New Segment Highlighting the Importance of Travel Health
As international travel starts to resume again, the topic of travel health is an important one to keep top of mind. In this new featured sponsored segment on The Balancing Act airing on Lifetime TV,...
Pandemic Preparedness: The next best time to act is now
By: Robert G. Kramer, CEO, Emergent – Global public health is at a critical inflection point. Do we learn the lessons of this pandemic and build a modern public health infrastructure to prepare...
Emergent Debuts New Campaign During Bowl Season
Emergent was pleased to debut our new campaign during the 2021 college football bowl season through a partnership with the Military Bowl to benefit our nation’s current and former service members....